Zusammenfassung
Die Mortalitätsrate von kolorektalen Karzinomen beträgt in mitteleuropäischen Ländern 10,8% bei Männern und 14,3% bei Frauen [19]. Etwa 25% der Patienten weisen schon bei Diagnosestellung des Karzinoms synchrone Lebermetastasen auf. Bei weiteren 30–40% entstehen im späteren Verlauf der Erkrankung (innerhalb von 2 Jahren) Absiedlungen des Primärtumors in der Leber (metachrone Metastasen), so daß Lebermetastasen als wichtiger prognosebestimmender Faktor beim kolorektalen Karzinom angesehen werden müssen [4].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Adams M, Moinuddin M, Boyd M (1982) Intra-arterial radionuclide infusion technique (Meeting Abstract). Clin Nucl Med 7 (105):72
Barone RM, Byfield JE, Goldfarb PB, Frankel S, Ginn C, Greer S (1982) Intra-arterial chemotherapy using an implantable infusion pump and liver irradiation for the treatment of hepatic metastases. Cancer 50:850–862
Bedikian AY, Chen TT, Malahy MA, Patt YZ, Bodey GP (1984) Prognostic factors influencing survival of patients with advanced colorectal cancer: Hepatic-artery infusion versus systemic intravenous chemotherapy for liver metastases. J Clin Oncol 2(3): 174–180
Bengmark S, Hafström L (1969) The natural history of primary and secondary malignant tumors of the liver. Cancer 23:198–202
Bonomi PD, Rossof AH, Raynor WJ et al. (1980) Prediction of survival duration in patients with metastatic measurable colorectal adenocarcinoma. Proc Am Soc Cancer Res 21:161
Dong K, Watson R, Pahnke L, Fortner J (1977) Tumor vascularity as a prognostic factor for hepatic tumors. Ann Surg 8(1):31–34
Gennari L, Doci R, Bozzetti F, Veronesi U (1982) Proposal for a clinical classification of liver metastases. Tumori 68:443–449
Goslin R, Steele G, Zamcheck N, Mayer R, MacIntyre J (1982) Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon and rectum. Dis Colon Rectum 25:749–754
Kaplan E, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Statist Ass 53:457
Kemeny N, Daly J, Reichman B, Geller N, Botet J, Oderman P (1987) Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. Ann Intern Med 107:459–465
Kemeny N, Niedzwiecki D, Shurgot B, Oderman P (1989) Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvement. Cancer 63:742–747
Lavin P, Mittelman A, Douglas H et al. (1980) Survival and response to chemotherapy for advanced colorectal adenocarcinoma. An Eastern Cooperative Oncology Group Report. Cancer 46:1536–1543
Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163
Pettavel J, Morgenthaler F (1969) Traitment chimiotherapique des metastases-hepatiques en function de leur évolution spontanée. Schweiz Med Wochenschr 130: 773–777
Safi F, Roscher R, Stahl S, Schumacher K, Pralle U, Bittner R, Beger HG (1987) Erfolgskontrolle der regionalen Chemotherapie der Metastasenleber durch arterielle Angio-Computertomographie. Tumor Diagn Ther 8:181–186
Safi F, Roscher R, Bittner R, Beger HG (1988) The clinical relevance of tumor marker CEA, CA 19–9 in regional chemotherapy of hepatic metastases of colorectal carcinoma. Int J Biol Markers 3(2):101–106
Safi F, Roscher R, Bittner R, Schumacher KA, Gaus W, Beger HG (1989) Regionale Chemotherapie von Lebermetastasen kolorektaler Karzinome. Dtsch Med Wochenschr 114:1478–1483
Safi F, Schumacher K, Roscher R, Bittner R, Beger HG (1989) Regional chemotherapy in liver metastases of colorectal carcinoma. Cancer Invest 8(2):117–128
Schön D, Bertz J, Hoffmeister H (1989) Bevölkerungsbezogene Krebsregister in der Bundesrepublik Deutschland, Bd 2. MMV Medizin Verlag, München
Wood CB, Gillis CR, Blumgart LH (1976) A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 2:285–288
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Safi, F., Roscher, R., Beger, H.B. (1991). Ansprechen der Lebermetastasen kolorektaler Karzinome unter FUDR-Therapie: Prognostische Kriterien. In: Herfarth, C., Schlag, P. (eds) Neue Entwicklungen in der Therapie von Lebertumoren. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76425-7_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-76425-7_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-76426-4
Online ISBN: 978-3-642-76425-7
eBook Packages: Springer Book Archive